Modra (Modulated Oral Drug Absorption) Pharmaceuticals B.V. is a spin-out from two internationally acclaimed centers of excellence in oncology, the ‘Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL)’ and the MC Slotervaart (Slotervaart) in Amsterdam. Modra Pharmaceuticals is a clinical stage company that develops new treatment paradigms by enabling oral bioavailability of existing anticancer drugs, “the iv to oral switch”, to improve cancer therapy and supportive care. Modra Pharmaceuticals has several products in preclinical and clinical development including oral formulations of docetaxel and paclitaxel.
| Website | http://www.modrapharmaceuticals.com |
| Employees | 7 (3 on RocketReach) |
| Founded | 2010 |
| Phone | +1 713-552-1091 |
| Technologies |
JavaScript
,
HTML
,
PHP
+6 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Oncology, Drug Development |
| Keywords | Oncology, Cancer Treatment, Drug Delivery, Pharmaceutical Research, Drug Absorption, Pharmaceutical Development, Drug Discovery, Oral Medications, New Drug Development, Innovative Therapies, Biotechnology, Clinical Trials, Therapeutic Solutions, Precision Medicine, Life Sciences, Healthcare, Patient Care |
| Competitors | Boehringer Ingelheim, Lilly India, Pfizer, Novartis, AbbVie, Roche, Johnson & Johnson, Merck & Co., Inc., Sanofi, Amgen +49 more (view full list) |
Looking for a particular Modra Pharmaceuticals employee's phone or email?
Eric van der Putten is the CEO of Modra Pharmaceuticals.
3 people are employed at Modra Pharmaceuticals.